Search Results 291-300 of 17370 for hba1c

1. Cataracts Clinical Trials - Mayo Clinic Research

   ... (HbA1c), and skin advanced glycation endproducts (AGE) and ... Outcome Measures for Clinical Trials in Pediatric Eye Care and Strabismus Rochester, MN. This ...

2. Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant - Mayo Clinic

   Participants with an established diagnosis of diabetes mellitus type I or participants with uncontrolled type II diabetes mellitus (FPG > 160 mg/dL and/or HbA1c ...

3. A Study Assessing the Effectiveness and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced Triple Negative Breast Cancer - Mayo Clinic

   Subject with an established diagnosis of diabetes mellitus type I or uncontrolled type II based on Fasting Plasma Glucose and HbA1c. Subject has impairment ...

4. Study of Sparsentan in Patients with Primary Focal Segmental Glomerulosclerosis - Mayo Clinic

   The patient has a history of type 1 diabetes mellitus, uncontrolled type 2 diabetes mellitus (hemoglobin A1c [HbA1c] > 8%), or nonfasting blood glucose ...

5. A Study of XmAb ®18087 in Subjects With NET and GIST - Mayo Clinic

   Poorly controlled diabetes mellitus as evidenced by an HbA1c level ≥ 10%, or significant diabetes-related dietary or therapeutic regimen changes within 12 ...

6. Empagliflozin and linagliptin (oral route) - Side effects & dosage - Mayo Clinic

   Empagliflozin and linagliptin combination is used together with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. It is also ...

7. Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder - Mayo Clinic

   Pugh class B or C) or poorly controlled diabetes (if diabetic, HbA1c > 8.0 within the preceding 6 months). 5. Subject has a concurrent neurological disease ...

8. A Study to Evaluate Genetic Testing in Guiding Treatment for Patients with Brain Metastases - Mayo Clinic

   Uncontrolled diabetes is defined as glycosylated hemoglobin (HbA1c) > 9% in addition to fasting glucose > 140 mg/dL on at least 2 occasions within 14 days prior ...

9. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

   ... (HbA1c) > 8.5%. Patients should be excluded if they have a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone ...

10. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

    Uncontrolled diabetes mellitus as defined by hemoglobin A1C (HbA1c) > 8% despite adequate therapy; unstable coronary artery disease or myocardial infarction ...